Antiplatelet drug

In a hospital setting, anticoagulants and antiplatelets are widely prescribed by physicians because of their greater benefits in changing the physiological homeostasis of the cardiovascular system. Anticoagulants and antiplatelets play a fundamental role in the treatment of cardiovascular diseases as they are very effective at counteracting the different symptoms cardiovascular diseases

Introduction Our body system is not immune to pathological deficiencies. There exist numerous identified pathologies which compromise the regular functioning of a heart, but all heart-related pathologies are narrowed to a single condition known as Acute Coronary Syndrome (ACS). This is the term properly used in reference to the different identified clinical entities threatening the cardiovascular system. ACS is the result of the progressive or complete sudden blocking of the arteries or veins;

Our comprehensive synthesis of available evidence showed a strong association between the LISA and the risk of late/very late ST and MI during the post imaging follow up. The low incidence of ST events over 18,145 person-months follow up (≈1.4% ST per person-year) in LISA group explains the limited power of previous studies evaluating this association. Our results are consistent with a prior meta-analysis of five studies which found LISA to be associated with increased risk of late ST (OR = 6.51;

The drug that will be discussed in this paper is Plavix. Plavix saves peoples veins and arteries from clotting, so it saves people’s lives every day. The pharmaceutical Drug Plavix is a blood thinner. Blood thinners are used to prevent heart attacks most commonly. Plavix is a blood thinner, which means it prevents the formation of blood clots in arteries, or veins. They do not get rid of existing clots, but they prevent them from getting any bigger. When blood thinners are taken with a drug called

hemorrhagic stroke. Objective: The aim is to conduct pharmacoepidemiology study on cerebro vascular accident patient by evaluating the use and the effects of drugs., and quantification of adverse drug reactions, drug utilization studies to improve the quality and use of medicines, designing interventions to improve prescribing pattern of drugs. Methodology: A prospective observational study was conducted in department of general medicine and ICU at mallareddy hospital, data was collected from

Platelet transfusion There is no fixed platelet count threshold in ICU patients that signals platelet transfusion (93), but because of hemorrhage fear there is a widespread notion that the platelet count should be maintained over 100X109/L in massive bleeding or when bleeding occurs at dangerous sites such as in intracranial hemorrhage (94). In addition to platelet count, the risk of hemorrhage is also dependent on the hematocrit and the bleeding time (95). So, red blood cell transfusion should also

patient, the drugs that he is on can lead to many severe side effects. Firstly he is on a number of medications that can cause CNS depression, hypotension, bradycardia, and sedation potentially leading to falls. Potential side effects prevalent with this patient of Omega 3 fatty acid include gi disturbances such as diarrhea, nausea, and constipation. With increased doses over 4 g or higher there may be a correlation with increased risk of bleeding. (cite ) Vitamin E may enhance antiplatelet effects

typically less than 5% of the applied drug penetrates the cornea and reaches intraocular tissues, while a major fraction of the instilled dose is absorbed and enters the systemic circulation. As ocular efficiency of topically applied drugs is influenced by the corneal contact time, most common method of improving ocular availability of drugs is to increase pre-corneal residence time by using vesicular system and hydrogel. One such approach to improve bioavailability of drug is the use of in-situ gelling

misunderstood drug that is thought of as dangerous but it isn’t. Because of people’s ignorance and gullibility marijuana has become illegal for all the wrong reasons and should be re-examined for legalization. Society today cannot understand that there has been a culture behind marijuana for many

400, 000 patients in 45 countries around the world with PIP Implants. The scandal was surfaced in year 2009 due to medical device reports from surgeons on the abnormally high rupture rates of the PIP implants than other approved implants. France’s drug and medical safety agency (AFSSAPS) recalled the PIP implants and advised 30,000 women to have their implants removed due to this scandal in subsequent year of 2010. 2.0 Issues with PIP implants A full recall of PIP implants by French Ministry of